It is a pharma private limited company based in Delhi, Delhi, India, established in 2021.
2021 | Delhi, Delhi, India | ActiveWelwart Pharmaceuticals Private Limited, a active private limited company, was established on 11 September 2021 in Delhi, Delhi, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24299DL2021PTC386408. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Asha Sharma (Director), Richa Sharma (Director), Kajal Tyagi (Director). Past directors included Asha Sharma, Anuj Kumar. Its latest AGM occurred on 02 September 2024, with the balance sheet filed on 31 March 2024. It is based at A-503 S/F G D Colony Mayur Vihar Ph-Iii, Delhi, Delhi, 110096.
U24299DL2021PTC386408
386408
11 September 2021
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Welwart Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Asha Sharma | Director | 11 Apr 2023 | Current |
| Richa Sharma | Director | 28 Dec 2023 | Current |
| Kajal Tyagi | Director | 11 Sep 2021 | Current |
| Anuj Kumar | Director | 03 Jan 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 03 Jan 2022 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Welwart Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 3360.75% increase. The company also saw a substantial improvement in profitability, with a 150.08% increase in profit. The company's net worth Soared by an impressive increase of 160.07%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Welwart Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Welwart Pharmaceuticals has a workforce of 0 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Welwart Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Welwart Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Welwart Pharmaceuticals Private Limited last Annual general meeting of members was held on 02 Sep 2024 as per latest MCA records. was recorded as a recent event.
Welwart Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
Progress on Richa Sharma was appointed as a Director was appointed as a Director on 28 Dec 2023 & has been associated with this company since 1 year 11 months . was documented.
Asha Sharma was appointed as a Director was appointed as a Director on 11 Apr 2023 & has been associated with this company since 2 years 7 months . was recorded as a recent event.
The activity Anuj Kumar was appointed as a Director was appointed as a Director on 03 Jan 2022 & has been associated with this company since 3 years 11 months . was completed.
Kajal Tyagi was appointed as a Director was appointed as a Director on 11 Sep 2021 & has been associated with this company since 4 years 2 months . was recorded as a recent event.
The CIN of Welwart Pharmaceuticals Private Limited is U24299DL2021PTC386408.
Welwart Pharmaceuticals Private Limited is headquartered at A-503 S/F G D Colony Mayur Vihar Ph-Iii, Delhi, Delhi, 110096.
Welwart Pharmaceuticals Private Limited was incorporated on 11 September 2021.
The current directors of Welwart Pharmaceuticals Private Limited are
The primary industry of Welwart Pharmaceuticals Private Limited is Trade.
Welwart Pharmaceuticals Private Limited is unlisted.
The authorized capital of Welwart Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX